Profile
| Metric | Value |
|---|---|
| Full Name | Anebulo Pharmaceuticals, Inc. |
| Ticker | NASDAQ: ANEB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | anebulo.com |
| Employees | 2 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.05 | ||
| Price, 1D Change | +20.00% | |
| $43M | ||
| - | ||
| - | ||
| 0.18 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.25 | ||
| EPS, 1Y Change | +21.00% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.25 | ||
| EPS Estimate | N/A | -$0.48 |
| EPS Est. Change | N/A | -91.31% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $1.05 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.45 | -$0.32 | +29.42% | |
| -$0.25 | -$0.25 | -0.36% | |
| -$0.48 | N/A | -91.31% | |
| -$0.46 | N/A | -83.34% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -33.96% | ||
| -56.25% | ||
| -33.96% | ||
| -29.88% | ||
| 0.00% | ||
| 0.00% | ||
| +21.00% | ||
| +14.19% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.05 | ||
| $1.89 | ||
| SMA 200 vs Price | +80.30% | |
| $1.65 | ||
| SMA 50 vs Price | +57.32% | |
| 0.18 | ||
| $0.12 | ||
| 39.43 | ||
| 143.46% | ||
| 124.68% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.25 | ||
| $0.00 | ||
| - | ||
| -$9.22M | ||
| - | ||
| -$8.48M | ||
| - | ||
| -$9.22M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 24.53 | ||
| 24.53 | ||
| - | ||
| - | ||
| 43.18 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 4.43 | ||
| -3.61 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $11.66M | ||
| $11.63M | ||
| $12.15M | ||
| $11.96M | ||
| $487.70K | ||
| $487.70K | ||
| $0.00 | ||
| $0.00 | ||
| $224.20K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $8.48M | ||
| $9.22M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$6.35M | ||
| $0.00 | ||
| $14.88M | ||
| $0.00 | ||
| -$6.35M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Maxim Group | → | |
| Maxim Group | → | |
| Benchmark | → | |
| Benchmark | → | |
| Benchmark | → | |
| HC Wainwright & Co. | → | |
| Maxim Group | ||
| HC Wainwright & Co. | ||
| Benchmark | → | |
| Benchmark |
Analyst sentiment
Institutional ownership
Screeners with ANEB
FAQ
What is the ticker symbol for Anebulo Pharmaceuticals, Inc.?
The ticker symbol for Anebulo Pharmaceuticals, Inc. is NASDAQ:ANEB
Does Anebulo Pharmaceuticals, Inc. pay dividends?
No, Anebulo Pharmaceuticals, Inc. does not pay dividends
What sector is Anebulo Pharmaceuticals, Inc. in?
Anebulo Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Anebulo Pharmaceuticals, Inc. in?
Anebulo Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Anebulo Pharmaceuticals, Inc. based in?
Anebulo Pharmaceuticals, Inc. is headquartered in United States
When did Anebulo Pharmaceuticals, Inc. go public?
Anebulo Pharmaceuticals, Inc. initial public offering (IPO) was on May 7, 2021
Is Anebulo Pharmaceuticals, Inc. in the S&P 500?
No, Anebulo Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Anebulo Pharmaceuticals, Inc. in the NASDAQ 100?
No, Anebulo Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Anebulo Pharmaceuticals, Inc. in the Dow Jones?
No, Anebulo Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Anebulo Pharmaceuticals, Inc. last earnings report?
Anebulo Pharmaceuticals, Inc.'s most recent earnings report was on September 24, 2025
When does Anebulo Pharmaceuticals, Inc. report earnings?
The date for Anebulo Pharmaceuticals, Inc.'s next earnings report has not been announced yet
Data Sources & References
- ANEB Official Website www.anebulo.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1815974/000149315225016015/0001493152-25-016015-index.htm
- ANEB Profile on Yahoo Finance finance.yahoo.com/quote/ANEB
- ANEB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aneb